+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Tumor Ablation Market Research Report by Technology, Treatment, Application, State - United States Forecast to 2027 - Cumulative Impact of COVID-19

  • PDF Icon

    Report

  • 124 Pages
  • October 2022
  • Region: United States
  • 360iResearch™
  • ID: 5124068
UP TO OFF until Dec 31st 2022
The United States Tumor Ablation Market size was estimated at USD 158.67 million in 2021, USD 199.18 million in 2022, and is projected to grow at a CAGR of 21.59% to reach USD 512.90 million by 2027.

Market Statistics:

The report provides market sizing and forecast across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Tumor Ablation to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Technology, the market was studied across Cryoablation, High-Intensity Focused Ultrasound, Laser Interstitial Thermal Ablation, Microwave Ablation, and Radiofrequency Ablation.
  • Based on Treatment, the market was studied across Laparoscopic Ablation, Percutaneous Ablation, and Surgical Ablation.
  • Based on Application, the market was studied across Bone Metastasis, Kidney Cancer, Liver Cancer, and Lung Cancer.
  • Based on State, the market was studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. This ongoing research amplifies This research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

The publisher continuously monitors and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Tumor Ablation market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tumor Ablation Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Tumor Ablation Market, including Angiodynamics, Inc., Boston Scientific Corp., BVM Medical Limited, Chongqing Haifu Medical Technology Co., Ltd., EDAP TMS S.A., Ethicon, Inc., Galil Medical, Inc., Healthtronics, Inc., HS Hospital Service S.P.A, Icecure, INTIO Inc., Medtronic, Plc., Mermaid Medical, Mesonix, Inc., NeuWave Medical, Inc., SonaCare Medical LLC., and Theraclion.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Tumor Ablation Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Tumor Ablation Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Tumor Ablation Market?
4. What is the competitive strategic window for opportunities in the United States Tumor Ablation Market?
5. What are the technology trends and regulatory frameworks in the United States Tumor Ablation Market?
6. What is the market share of the leading vendors in the United States Tumor Ablation Market?
7. What modes and strategic moves are considered suitable for entering the United States Tumor Ablation Market?
Frequently Asked Questions about the U.S. Tumor Ablation Market

What is the estimated value of the U.S. Tumor Ablation Market?

The U.S. Tumor Ablation Market was estimated to be valued at $158.67 Million in 2021.

What is the growth rate of the U.S. Tumor Ablation Market?

The growth rate of the U.S. Tumor Ablation Market is 21.5%, with an estimated value of $512.9 Million by 2027.

What is the forecasted size of the U.S. Tumor Ablation Market?

The U.S. Tumor Ablation Market is estimated to be worth $512.9 Million by 2027.

Who are the key companies in the U.S. Tumor Ablation Market?

Key companies in the U.S. Tumor Ablation Market include Angiodynamics, Inc., Boston Scientific Corp., BVM Medical Limited, Chongqing Haifu Medical Technology Co., Ltd., EDAP TMS S.A., Ethicon, Inc., Galil Medical, Inc., Healthtronics, Inc. and Icecure.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Opportunities
5.1.4. Challenges
5.2. Cumulative Impact of COVID-19
6. Tumor Ablation Market, by Technology
6.1. Introduction
6.2. Cryoablation
6.3. High-Intensity Focused Ultrasound
6.4. Laser Interstitial Thermal Ablation
6.5. Microwave Ablation
6.6. Radiofrequency Ablation
7. Tumor Ablation Market, by Treatment
7.1. Introduction
7.2. Laparoscopic Ablation
7.3. Percutaneous Ablation
7.4. Surgical Ablation
8. Tumor Ablation Market, by Application
8.1. Introduction
8.2. Bone Metastasis
8.3. Kidney Cancer
8.4. Liver Cancer
8.5. Lung Cancer
9. California Tumor Ablation Market
9.1. Introduction
10. Florida Tumor Ablation Market
10.1. Introduction
11. Illinois Tumor Ablation Market
11.1. Introduction
12. New York Tumor Ablation Market
12.1. Introduction
13. Ohio Tumor Ablation Market
13.1. Introduction
14. Pennsylvania Tumor Ablation Market
14.1. Introduction
15. Texas Tumor Ablation Market
15.1. Introduction
16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Competitive Scenario
16.4.1. Merger & Acquisition
16.4.2. Agreement, Collaboration, & Partnership
16.4.3. New Product Launch & Enhancement
16.4.4. Investment & Funding
16.4.5. Award, Recognition, & Expansion
17. Company Usability Profiles
17.1. Angiodynamics, Inc.
17.1.1. Business Overview
17.1.2. Key Executives
17.1.3. Product & Services
17.2. Boston Scientific Corp.
17.2.1. Business Overview
17.2.2. Key Executives
17.2.3. Product & Services
17.3. BVM Medical Limited
17.3.1. Business Overview
17.3.2. Key Executives
17.3.3. Product & Services
17.4. Chongqing Haifu Medical Technology Co., Ltd.
17.4.1. Business Overview
17.4.2. Key Executives
17.4.3. Product & Services
17.5. EDAP TMS S.A.
17.5.1. Business Overview
17.5.2. Key Executives
17.5.3. Product & Services
17.6. Ethicon, Inc.
17.6.1. Business Overview
17.6.2. Key Executives
17.6.3. Product & Services
17.7. Galil Medical, Inc.
17.7.1. Business Overview
17.7.2. Key Executives
17.7.3. Product & Services
17.8. Healthtronics, Inc.
17.8.1. Business Overview
17.8.2. Key Executives
17.8.3. Product & Services
17.9. HS Hospital Service S.P.A
17.9.1. Business Overview
17.9.2. Key Executives
17.9.3. Product & Services
17.10. Icecure
17.10.1. Business Overview
17.10.2. Key Executives
17.10.3. Product & Services
17.11. INTIO Inc.
17.11.1. Business Overview
17.11.2. Key Executives
17.11.3. Product & Services
17.12. Medtronic, Plc.
17.12.1. Business Overview
17.12.2. Key Executives
17.12.3. Product & Services
17.13. Mermaid Medical
17.13.1. Business Overview
17.13.2. Key Executives
17.13.3. Product & Services
17.14. Mesonix, Inc.
17.14.1. Business Overview
17.14.2. Key Executives
17.14.3. Product & Services
17.15. NeuWave Medical, Inc.
17.15.1. Business Overview
17.15.2. Key Executives
17.15.3. Product & Services
17.16. SonaCare Medical LLC.
17.16.1. Business Overview
17.16.2. Key Executives
17.16.3. Product & Services
17.17. Theraclion
17.17.1. Business Overview
17.17.2. Key Executives
17.17.3. Product & Services
18. Appendix
18.1. Discussion Guide
18.2. License & Pricing
List of Figures
FIGURE 1. UNITED STATES TUMOR ABLATION MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES TUMOR ABLATION MARKET SIZE, 2021 VS 2027
FIGURE 3. UNITED STATES TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 4. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2021 VS 2027 (%)
FIGURE 5. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2021 VS 2027 (USD MILLION)
FIGURE 6. UNITED STATES TUMOR ABLATION MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2027
FIGURE 7. UNITED STATES TUMOR ABLATION MARKET DYNAMICS
FIGURE 8. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 9. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 10. UNITED STATES TUMOR ABLATION MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2027
FIGURE 11. UNITED STATES TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, 2018-2027 (USD MILLION)
FIGURE 12. UNITED STATES TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, 2018-2027 (USD MILLION)
FIGURE 13. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, 2018-2027 (USD MILLION)
FIGURE 14. UNITED STATES TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, 2018-2027 (USD MILLION)
FIGURE 15. UNITED STATES TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2027 (USD MILLION)
FIGURE 16. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2021 VS 2027 (%)
FIGURE 17. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2021 VS 2027 (USD MILLION)
FIGURE 18. UNITED STATES TUMOR ABLATION MARKET COMPETITIVE STRATEGIC WINDOW, BY TREATMENT, 2027
FIGURE 19. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, 2018-2027 (USD MILLION)
FIGURE 20. UNITED STATES TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, 2018-2027 (USD MILLION)
FIGURE 21. UNITED STATES TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, 2018-2027 (USD MILLION)
FIGURE 22. UNITED STATES TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 23. UNITED STATES TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 24. UNITED STATES TUMOR ABLATION MARKET COMPETITIVE STRATEGIC WINDOW, BY APPLICATION, 2027
FIGURE 25. UNITED STATES TUMOR ABLATION MARKET SIZE, BY BONE METASTASIS, 2018-2027 (USD MILLION)
FIGURE 26. UNITED STATES TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, 2018-2027 (USD MILLION)
FIGURE 27. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, 2018-2027 (USD MILLION)
FIGURE 28. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, 2018-2027 (USD MILLION)
FIGURE 29. CALIFORNIA TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 30. FLORIDA TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 31. ILLINOIS TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 32. NEW YORK TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 33. OHIO TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 34. PENNSYLVANIA TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 35. TEXAS TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 36. UNITED STATES TUMOR ABLATION MARKET: FPNV POSITIONING MATRIX, 2021
FIGURE 37. UNITED STATES TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2021
FIGURE 38. UNITED STATES TUMOR ABLATION MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2021
List of Tables
TABLE 1. UNITED STATES TUMOR ABLATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2021
TABLE 3. UNITED STATES TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 4. UNITED STATES TUMOR ABLATION MARKET SIZE, BY STATE, 2018-2027 (USD MILLION)
TABLE 5. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, 2018-2027 (USD MILLION)
TABLE 7. UNITED STATES TUMOR ABLATION MARKET SIZE, BY CRYOABLATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 8. UNITED STATES TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, 2018-2027 (USD MILLION)
TABLE 9. UNITED STATES TUMOR ABLATION MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY STATE, 2018-2027 (USD MILLION)
TABLE 10. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LASER INTERSTITIAL THERMAL ABLATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. UNITED STATES TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, 2018-2027 (USD MILLION)
TABLE 13. UNITED STATES TUMOR ABLATION MARKET SIZE, BY MICROWAVE ABLATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 14. UNITED STATES TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, 2018-2027 (USD MILLION)
TABLE 15. UNITED STATES TUMOR ABLATION MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 17. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, 2018-2027 (USD MILLION)
TABLE 18. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LAPAROSCOPIC ABLATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 19. UNITED STATES TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, 2018-2027 (USD MILLION)
TABLE 20. UNITED STATES TUMOR ABLATION MARKET SIZE, BY PERCUTANEOUS ABLATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, 2018-2027 (USD MILLION)
TABLE 22. UNITED STATES TUMOR ABLATION MARKET SIZE, BY SURGICAL ABLATION, BY STATE, 2018-2027 (USD MILLION)
TABLE 23. UNITED STATES TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 24. UNITED STATES TUMOR ABLATION MARKET SIZE, BY BONE METASTASIS, 2018-2027 (USD MILLION)
TABLE 25. UNITED STATES TUMOR ABLATION MARKET SIZE, BY BONE METASTASIS, BY STATE, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, 2018-2027 (USD MILLION)
TABLE 27. UNITED STATES TUMOR ABLATION MARKET SIZE, BY KIDNEY CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 28. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, 2018-2027 (USD MILLION)
TABLE 29. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LIVER CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 30. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES TUMOR ABLATION MARKET SIZE, BY LUNG CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. CALIFORNIA TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 33. CALIFORNIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 34. CALIFORNIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 35. CALIFORNIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 36. FLORIDA TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 37. FLORIDA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 38. FLORIDA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 39. FLORIDA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 40. ILLINOIS TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 41. ILLINOIS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 42. ILLINOIS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 43. ILLINOIS TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 44. NEW YORK TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 45. NEW YORK TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 46. NEW YORK TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 47. NEW YORK TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 48. OHIO TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 49. OHIO TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 50. OHIO TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 51. OHIO TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 52. PENNSYLVANIA TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 53. PENNSYLVANIA TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 54. PENNSYLVANIA TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 55. PENNSYLVANIA TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 56. TEXAS TUMOR ABLATION MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 57. TEXAS TUMOR ABLATION MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 58. TEXAS TUMOR ABLATION MARKET SIZE, BY TREATMENT, 2018-2027 (USD MILLION)
TABLE 59. TEXAS TUMOR ABLATION MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 60. UNITED STATES TUMOR ABLATION MARKET: FPNV POSITIONING MATRIX - SCORES, 2021
TABLE 61. UNITED STATES TUMOR ABLATION MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2021
TABLE 62. UNITED STATES TUMOR ABLATION MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2021
TABLE 63. UNITED STATES TUMOR ABLATION MARKET RANKING, BY KEY PLAYER, 2021
TABLE 64. UNITED STATES TUMOR ABLATION MARKET SHARE, BY KEY PLAYER, 2021
TABLE 65. UNITED STATES TUMOR ABLATION MARKET MERGER & ACQUISITION
TABLE 66. UNITED STATES TUMOR ABLATION MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 67. UNITED STATES TUMOR ABLATION MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 68. UNITED STATES TUMOR ABLATION MARKET INVESTMENT & FUNDING
TABLE 69. UNITED STATES TUMOR ABLATION MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 70. UNITED STATES TUMOR ABLATION MARKET: LICENSE & PRICING

Companies Mentioned

  • Angiodynamics, Inc.
  • Boston Scientific Corp.
  • BVM Medical Limited
  • Chongqing Haifu Medical Technology Co., Ltd.
  • EDAP TMS S.A.
  • Ethicon, Inc.
  • Galil Medical, Inc.
  • Healthtronics, Inc.
  • HS Hospital Service S.P.A
  • Icecure
  • INTIO Inc.
  • Medtronic, Plc.
  • Mermaid Medical
  • Mesonix, Inc.
  • NeuWave Medical, Inc.
  • SonaCare Medical LLC.
  • Theraclion

Methodology

Loading
LOADING...